Sec Form 4 Filing - KONINKLIJKE PHILIPS NV @ Corindus Vascular Robotics, Inc. - 2017-02-28

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KONINKLIJKE PHILIPS NV 2. Issuer Name and Ticker or Trading Symbol Corindus Vascular Robotics, Inc. [ CVRS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC 3. Date of Earliest Transaction (MM/DD/YY) 02/28/2017 (Street) AMSTERDAM, P7 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.0001 per share 02/28/2017 P( 1 ) 7,557,436 A $ 0.6616 24,965,253 ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant $ 1.06 08/12/2014 10/11/2017 Common Stock, par value $0.0001 per share 4,728,191 4,728,191 ( 2 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other KONINKLIJKE PHILIPS NV PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC AMSTERDAM, P7 X Signatures /s/ Abhijit Bhattacharya, Chief Financial Officer 03/10/2017 Signature of Reporting Person Date /s/ Marnix van Ginneken, Chief Legal Officer 03/10/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Pursuant to the Securities Purchase Agreement, dated February 28, 2017, by and among Corindus Vascular Robotics, Inc. (the "Company"), Koninklijke Philips N.V. ("Philips") and the other parties thereto, Philips has the right to acquire 7,557,436 shares of common stock of the Company, par value $0.0001 per share (the "Common Stock") at the closing scheduled for March 15, 2017, for a purchase price of $0.6616 per share. ( 2 )This amount reflects a correction to the Form 3, filed by Philips on February 28, 2017, clarifying that 4,728,191 shares of Common Stock beneficially owned by Philips are in the form of warrants. The correction does not result in any change in the overall number of shares of Common Stock beneficially owned by Philips as of the date of such Form 3 filing.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.